Neurogene (NGNE.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Nov14

Neurogene released FY2025 9 Months earnings on November 13 (EST), actual revenue USD 0, actual EPS USD -3.114

04:00

Neurogene released FY2025 Q3 earnings on November 13 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.9898 (forecast USD -1.25)

04:00

Nov13

Neurogene Inc. Releases Rare Neurological Disease Development Progress

23:06

Nov7

Analyst Maintains Buy Rating on Neurogene with a Price Target of $65.00

16:41

Oct10

HC Wainwright Reiterates Neurogene's 'Buy' Rating With a Price Target of $45.00

14:45

Aug12

Neurogene released FY2025 Q2 earnings on August 11 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -1.0456 (forecast USD -1.16)

03:00

Schedules & Filings

Schedules

Filings

Nov13

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -20.95 M, EPS -0.9898

Aug11

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -22.02 M, EPS -1.0456

May9

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -22.65 M, EPS -1.0786

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More